The International Olympic Committee today announced that seven samples taken during the Olympic Games in Beijing had resulted in “adverse analytical findings”.
Those findings relate to six separate athletes and were all for CERA, the new version of an endurance-enhancing hormone.
The IOC is currently notifying the athletes in question through their National Olympic Committee.
Any necessary disciplinary procedures, including hearings, will be conducted based upon the IOC’s anti-doping rules. Pending the decision by the IOC, appropriate steps can be taken by the relevant International Federation, in particular with respect to provisional suspension.
“The further analysis of the Beijing samples that we conducted should send a clear message that cheats can never assume that they have avoided detection,” said Arne Ljungqvist, chairman of the IOC medical commission.
“The vast majority of athletes do not seek an unfair advantage. We intend to do all we can to ensure that they have a fair environment for competition.”